date,study,study_link,journal,severe,severe_lower_bound,severe_upper_bound,severe_p-value,severe_significant,fatality,fatality_lower_bound,fatality_upper_bound,fatality_p-value,fatality_significant,fatality_adjusted,fatality_calculated,multivariate_adjustment,study_type,sample_size,study_population,critical_only,discharged_vs._death?,key_word,Severe_number,Fatality_number,severe_outside_bounds,fatality_outside_bounds,context
2020-06-30,Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis,https://doi.org/10.1016/j.jcv.2020.104371,Journal of Virology,,,,,,ES=0.44,0.27,0.62,<0.05,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,"21 Studies, 47,344 patients","Medline, Sino Med, EMBASE, and Cochrane Library databases from Jan 1, 2020 to Mar 10, 2020",N,N,['redirecting'],,0.44,0,0,"Date: 2020-06-30. Study: Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. Study Link: https://doi.org/10.1016/j.jcv.2020.104371. Journal: Journal of Virology. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : ES=0.44. Fatality lower bound : 0.27. Fatality upper bound: 0.62. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 21 Studies, 47,344 patients. Study Population: Medline, Sino Med, EMBASE, and Cochrane Library databases from Jan 1, 2020 to Mar 10, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 0.44. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-06-30,"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China",https://doi.org/10.1016/j.jcv.2020.104364,Journal of Clinical Virology,OR 1.47,0.57,3.81,0.43,Not Significant,,,,,,,,,Retrospective observational study,221,"Zhongnan Hospital of Wuhan University, Wuhan, China from January 2, 2020 to February 10, 2020",N,N,['redirecting'],1.47,,0,0,"Date: 2020-06-30. Study: Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Study Link: https://doi.org/10.1016/j.jcv.2020.104364. Journal: Journal of Clinical Virology. Severe: OR 1.47. Severe Lower Bound: 0.57. Severe Upper Bound: 3.81. Severe p-value: 0.43. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 221. Study Population: Zhongnan Hospital of Wuhan University, Wuhan, China from January 2, 2020 to February 10, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 1.47. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-06-04,Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.,https://doi.org/10.1111/dom.14105,"Diabetes, obesity & metabolism",OR=2.58,1.93,3.45,,Significant,OR=2.95,1.93,4.53,,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,2116,"PubMed, Embase, medRxiv,  Cochrane library,  and CNKI databases for articles published up  to 03/20/2020",N,N,[],2.58,2.95,0,0,"Date: 2020-06-04. Study: Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.. Study Link: https://doi.org/10.1111/dom.14105. Journal: Diabetes, obesity & metabolism. Severe: OR=2.58. Severe Lower Bound: 1.93. Severe Upper Bound: 3.45. Severe p-value: nan. Severe Significant: Significant. Fatalyty : OR=2.95. Fatality lower bound : 1.93. Fatality upper bound: 4.53. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 2116. Study Population: PubMed, Embase, medRxiv,  Cochrane library,  and CNKI databases for articles published up  to 03/20/2020. Critical Only: N. Discharged vs Death: N.Severe_number: 2.58. Fatality_number: 2.95. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-06-04,Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.,https://doi.org/10.1111/dom.14105,"Diabetes, obesity & metabolism",AOR=5.29,1.07,26.02,<0.05,Significant,,,,,,,,Age; Gender,Retrospective observational study,66,"Huai'an Fourth people's hospital from Jan 23, 2020 to Mar 9, 2020",N,N,[],5.29,,0,0,"Date: 2020-06-04. Study: Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.. Study Link: https://doi.org/10.1111/dom.14105. Journal: Diabetes, obesity & metabolism. Severe: AOR=5.29. Severe Lower Bound: 1.07. Severe Upper Bound: 26.02. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: Age; Gender. Study Type: Retrospective observational study. Sample Size: 66. Study Population: Huai'an Fourth people's hospital from Jan 23, 2020 to Mar 9, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 5.29. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-06-04,Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.,https://doi.org/10.1111/dom.14105,"Diabetes, obesity & metabolism",OR=4.67,1.19,18.26,<0.05,Significant,,,,,,,,,Retrospective observational study,66,"Huai'an Fourth people's hospital from Jan 23, 2020 to Mar 9, 2020",N,N,[],4.67,,0,0,"Date: 2020-06-04. Study: Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.. Study Link: https://doi.org/10.1111/dom.14105. Journal: Diabetes, obesity & metabolism. Severe: OR=4.67. Severe Lower Bound: 1.19. Severe Upper Bound: 18.26. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 66. Study Population: Huai'an Fourth people's hospital from Jan 23, 2020 to Mar 9, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 4.67. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-06-03,Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19,https://doi.org/10.2217/bmm-2020-0254,Biomarkers in medicine,OR 1.62,0.74,3.54,0.23,Not Significant,,,,,,,,,Retrospective observational study,134,Central Hospital of Wuhan from 1 January to 20 February 2020,Y,N,[],1.62,,0,0,Date: 2020-06-03. Study: Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Study Link: https://doi.org/10.2217/bmm-2020-0254. Journal: Biomarkers in medicine. Severe: OR 1.62. Severe Lower Bound: 0.74. Severe Upper Bound: 3.54. Severe p-value: 0.23. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 134. Study Population: Central Hospital of Wuhan from 1 January to 20 February 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.62. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. 
2020-06-01,COVID-19 with Different Severities: A Multicenter Study of Clinical Features,https://www.ncbi.nlm.nih.gov/pubmed/32275452/,Am J Respir Crit Care Med,OR 0.79,0.32,1.94,0.61,Not Significant,,,,,,,,,Retrospective observational study,476,"Jinyintan Hospital in Wuhan, Shanghai Public Health Clinical Center in Shanghai, and Tongling People’s Hospital in Anhui Province, China from January 1, 2020, to February 15, 2020.",Y,N,"['cases', 'clusters', 'transmission', 'community', 'sporadic']",0.79,,0,0,"Date: 2020-06-01. Study: COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32275452/. Journal: Am J Respir Crit Care Med. Severe: OR 0.79. Severe Lower Bound: 0.32. Severe Upper Bound: 1.94. Severe p-value: 0.61. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 476. Study Population: Jinyintan Hospital in Wuhan, Shanghai Public Health Clinical Center in Shanghai, and Tongling People’s Hospital in Anhui Province, China from January 1, 2020, to February 15, 2020.. Critical Only: Y. Discharged vs Death: N.Severe_number: 0.79. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['cases', 'clusters', 'transmission', 'community', 'sporadic']. "
2020-06-01,Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System,http://medrxiv.org/cgi/content/short/2020.05.29.20086645v1?rss=1,MedRxiv,,,,,,OR 1.13,1.0,1.27,0.05,Significant,Not Adjusted,Calculated,,Retrospective observational study,13442,"New York City Health and Hospital between March 5 and April 9, 2020",N,N,"['patients', 'preprint', 'new', 'medrxiv', 'york']",,1.13,0,0,"Date: 2020-06-01. Study: Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System. Study Link: http://medrxiv.org/cgi/content/short/2020.05.29.20086645v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.13. Fatality lower bound : 1.0. Fatality upper bound: 1.27. Fatality p-value: 0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 13442. Study Population: New York City Health and Hospital between March 5 and April 9, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.13. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'preprint', 'new', 'medrxiv', 'york']. "
2020-05-31,Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19,https://www.sciencedirect.com/science/article/pii/S120197122030415X?v=s5,Int J Infect Dis,,,,,,HR=1.1,0.6,1.9,0.88,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,204,"Renmin  Hospital  of  Wuhan University  from  January 31 to February  20, 2020",N,N,[],,1.1,0,0,"Date: 2020-05-31. Study: Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19. Study Link: https://www.sciencedirect.com/science/article/pii/S120197122030415X?v=s5. Journal: Int J Infect Dis. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : HR=1.1. Fatality lower bound : 0.6. Fatality upper bound: 1.9. Fatality p-value: 0.88. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 204. Study Population: Renmin  Hospital  of  Wuhan University  from  January 31 to February  20, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.1. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-29,A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.,https://doi.org/10.1016/j.jinf.2020.05.064,J Infect,HR=1.42,1.04,1.95,<0.05,Significant,HR=1.24,0.95,1.6,0.11,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,1157,"King’s College Hospital and Princess Royal University Hospital from March 1, 2020 and April 17, 2020",Y,N,['redirecting'],1.42,1.24,0,0,"Date: 2020-05-29. Study: A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.. Study Link: https://doi.org/10.1016/j.jinf.2020.05.064. Journal: J Infect. Severe: HR=1.42. Severe Lower Bound: 1.04. Severe Upper Bound: 1.95. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : HR=1.24. Fatality lower bound : 0.95. Fatality upper bound: 1.6. Fatality p-value: 0.11. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 1157. Study Population: King’s College Hospital and Princess Royal University Hospital from March 1, 2020 and April 17, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.42. Fatality_number: 1.24. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-05-28,Obesity and COVID-19: an Italian snapshot,https://www.ncbi.nlm.nih.gov/pubmed/32463545/,Obesity,,,,,,OR: 2.06,0.19,22.44,0.55,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,92,"92 patients stayed at least one day in the COVID-19 medical ward from March 23 to April 11, 2020",N,N,"['patients', 'p', 'obesity', 'severe', 'age']",,2.06,0,0,"Date: 2020-05-28. Study: Obesity and COVID-19: an Italian snapshot. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32463545/. Journal: Obesity. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR: 2.06. Fatality lower bound : 0.19. Fatality upper bound: 22.44. Fatality p-value: 0.55. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 92. Study Population: 92 patients stayed at least one day in the COVID-19 medical ward from March 23 to April 11, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 2.06. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'p', 'obesity', 'severe', 'age']. "
2020-05-28,"Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients",http://medrxiv.org/cgi/content/short/2020.05.26.20113811v1?rss=1,MedRxiv,,,,,,OR=1.65,1.35,1.96,,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,18506,"Medline, Embase, Google Scholar, and medRxiv (the preprint server for health sciences) up to May 10, 2020",N,N,"['preprint', 'medrxiv', 'license', 'na', 'diabetes']",,1.65,0,0,"Date: 2020-05-28. Study: Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. Study Link: http://medrxiv.org/cgi/content/short/2020.05.26.20113811v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR=1.65. Fatality lower bound : 1.35. Fatality upper bound: 1.96. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 18506. Study Population: Medline, Embase, Google Scholar, and medRxiv (the preprint server for health sciences) up to May 10, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.65. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'medrxiv', 'license', 'na', 'diabetes']. "
2020-05-26,COVID-19: Impact of Obesity and Diabetes in Disease Severity,http://medrxiv.org/cgi/content/short/2020.05.24.20111724v1?rss=1,MedRxiv,AOR=5.49,3.13,9.65,<0.05,Significant,,,,,,,,Age; Gender; Diabetes; Hypertension,Retrospective observational study,1158,Jaber Al-Ahmad Al-Sabah Hospital in Kuwait from 24 February to 7 April 2020.,Y,N,"['patients', 'icu', 'preprint', 'obesity', 'diabetes']",5.49,,0,0,"Date: 2020-05-26. Study: COVID-19: Impact of Obesity and Diabetes in Disease Severity. Study Link: http://medrxiv.org/cgi/content/short/2020.05.24.20111724v1?rss=1. Journal: MedRxiv. Severe: AOR=5.49. Severe Lower Bound: 3.13. Severe Upper Bound: 9.65. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: Age; Gender; Diabetes; Hypertension. Study Type: Retrospective observational study. Sample Size: 1158. Study Population: Jaber Al-Ahmad Al-Sabah Hospital in Kuwait from 24 February to 7 April 2020.. Critical Only: Y. Discharged vs Death: N.Severe_number: 5.49. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'icu', 'preprint', 'obesity', 'diabetes']. "
2020-05-26,COVID-19: Impact of Obesity and Diabetes in Disease Severity,http://medrxiv.org/cgi/content/short/2020.05.24.20111724v1?rss=1,MedRxiv,OR=9.38,5.49,16.02,<0.05,Significant,,,,,,,,,Retrospective observational study,1158,Jaber Al-Ahmad Al-Sabah Hospital in Kuwait from 24 February to 7 April 2020.,Y,N,"['patients', 'icu', 'preprint', 'obesity', 'diabetes']",9.38,,0,0,"Date: 2020-05-26. Study: COVID-19: Impact of Obesity and Diabetes in Disease Severity. Study Link: http://medrxiv.org/cgi/content/short/2020.05.24.20111724v1?rss=1. Journal: MedRxiv. Severe: OR=9.38. Severe Lower Bound: 5.49. Severe Upper Bound: 16.02. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 1158. Study Population: Jaber Al-Ahmad Al-Sabah Hospital in Kuwait from 24 February to 7 April 2020.. Critical Only: Y. Discharged vs Death: N.Severe_number: 9.38. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'icu', 'preprint', 'obesity', 'diabetes']. "
2020-05-26,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",http://medrxiv.org/cgi/content/short/2020.05.24.20111823v1?rss=1,MedRxiv,,,,,,AOR=1.6,1.3,2.1,,Significant,Adjusted,Extracted,Age; Sex,Retrospective observational study,9519,"Danish SARS-CoV-2 cohort from February 27th, 2020 to April 30th, 2020",Y,N,"['preprint', 'cases', 'comorbidities', 'medrxiv', 'disease']",,1.6,0,0,"Date: 2020-05-26. Study: Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort. Study Link: http://medrxiv.org/cgi/content/short/2020.05.24.20111823v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AOR=1.6. Fatality lower bound : 1.3. Fatality upper bound: 2.1. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age; Sex. Study Type: Retrospective observational study. Sample Size: 9519. Study Population: Danish SARS-CoV-2 cohort from February 27th, 2020 to April 30th, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.6. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'cases', 'comorbidities', 'medrxiv', 'disease']. "
2020-05-26,"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort",http://medrxiv.org/cgi/content/short/2020.05.24.20111823v1?rss=1,MedRxiv,OR 1.34,1.0,1.8,0.05,Significant,OR=4.4,3.6,5.4,,Significant,Not Adjusted,Extracted,,Retrospective observational study,9519,"Danish SARS-CoV-2 cohort from February 27th, 2020 to April 30th, 2020",Y,N,"['preprint', 'cases', 'comorbidities', 'medrxiv', 'disease']",1.34,4.4,0,0,"Date: 2020-05-26. Study: Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: A nationwide cohort. Study Link: http://medrxiv.org/cgi/content/short/2020.05.24.20111823v1?rss=1. Journal: MedRxiv. Severe: OR 1.34. Severe Lower Bound: 1.0. Severe Upper Bound: 1.8. Severe p-value: 0.05. Severe Significant: Significant. Fatalyty : OR=4.4. Fatality lower bound : 3.6. Fatality upper bound: 5.4. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 9519. Study Population: Danish SARS-CoV-2 cohort from February 27th, 2020 to April 30th, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.34. Fatality_number: 4.4. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'cases', 'comorbidities', 'medrxiv', 'disease']. "
2020-05-26,Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-23,http://medrxiv.org/cgi/content/short/2020.05.22.20109355v1?rss=1,MedRxiv,OR 0.92,0.39,2.16,0.84,Not Significant,,,,,,,,,Retrospective observational study,104,"consecutive patients admitted to Temple University Hospital in Philadelphia, Pennsylvania, from March 10, 2020, to April 24, 2020, for moderate to severe hypoxemia due to highly suspected or proven COVID-19 infection",Y,N,"['preprint', 'patients', 'medrxiv', 'hfnt', 'respiratory']",0.92,,0,0,"Date: 2020-05-26. Study: Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-23. Study Link: http://medrxiv.org/cgi/content/short/2020.05.22.20109355v1?rss=1. Journal: MedRxiv. Severe: OR 0.92. Severe Lower Bound: 0.39. Severe Upper Bound: 2.16. Severe p-value: 0.84. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 104. Study Population: consecutive patients admitted to Temple University Hospital in Philadelphia, Pennsylvania, from March 10, 2020, to April 24, 2020, for moderate to severe hypoxemia due to highly suspected or proven COVID-19 infection. Critical Only: Y. Discharged vs Death: N.Severe_number: 0.92. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'patients', 'medrxiv', 'hfnt', 'respiratory']. "
2020-05-26,ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019,https://doi.org/10.1097/ccm.0000000000004457,Crit Care Med,,,,,,OR 1.08,0.59,1.96,0.8,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,217,"ICU of Emory Healthcare acute-care hospitals in Atlanta, Georgia from March 6, 2020, to April 17, 2025",N,N,[],,1.08,0,0,"Date: 2020-05-26. Study: ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019. Study Link: https://doi.org/10.1097/ccm.0000000000004457. Journal: Crit Care Med. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.08. Fatality lower bound : 0.59. Fatality upper bound: 1.96. Fatality p-value: 0.8. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 217. Study Population: ICU of Emory Healthcare acute-care hospitals in Atlanta, Georgia from March 6, 2020, to April 17, 2025. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.08. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-26,"Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases",http://medrxiv.org/cgi/content/short/2020.05.23.20110965v1?rss=1,MedRxiv,,,,,,OR=2.45,1.82,3.3,<0.05,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,"85 articles, 67299 cases","PubMed, ScienceDirect, and SAGE database from January 1, 2020, to May 17, 2020",N,N,"['preprint', 'study', 'china', 'clinical', 'patients']",,2.45,0,0,"Date: 2020-05-26. Study: Association of age, sex, comorbidities, and clinical symptoms with the severity and mortality of COVID-19 cases: a meta-analysis with 85 studies and 67299 cases. Study Link: http://medrxiv.org/cgi/content/short/2020.05.23.20110965v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR=2.45. Fatality lower bound : 1.82. Fatality upper bound: 3.3. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 85 articles, 67299 cases. Study Population: PubMed, ScienceDirect, and SAGE database from January 1, 2020, to May 17, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 2.45. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'study', 'china', 'clinical', 'patients']. "
2020-05-25,Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246302/,Int J Public Health,OR 2.72,0.7,10.6,,Not Significant,,,,,,,,,Systematic review and meta-analysis,Not reported out of 7 studies enrolling 2912 patients,"MEDLINE, EMBASE and Global Health",Y,N,[],2.72,,0,0,"Date: 2020-05-25. Study: Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Study Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246302/. Journal: Int J Public Health. Severe: OR 2.72. Severe Lower Bound: 0.7. Severe Upper Bound: 10.6. Severe p-value: nan. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: Not reported out of 7 studies enrolling 2912 patients. Study Population: MEDLINE, EMBASE and Global Health. Critical Only: Y. Discharged vs Death: N.Severe_number: 2.72. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-25,Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246302/,Int J Public Health,OR 3.12,1.0,9.75,,Significant,,,,,,,,,Systematic review and meta-analysis,Not reported out of 7 studies enrolling 2912 patients,"MEDLINE, EMBASE and Global Health",N,N,[],3.12,,0,0,"Date: 2020-05-25. Study: Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Study Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246302/. Journal: Int J Public Health. Severe: OR 3.12. Severe Lower Bound: 1.0. Severe Upper Bound: 9.75. Severe p-value: nan. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: Not reported out of 7 studies enrolling 2912 patients. Study Population: MEDLINE, EMBASE and Global Health. Critical Only: N. Discharged vs Death: N.Severe_number: 3.12. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-25,Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences,http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1,MedRxiv,,,,,,AHR=1.35,1.13,1.62,,Significant,Adjusted,Extracted,Age; Gender; Address; Clinical Severity,Retrospective observational study,18465,"Hubei Province as of February 27,2020 followed up to March 7, 2020",N,N,"['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']",,1.35,0,0,"Date: 2020-05-25. Study: Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences. Study Link: http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=1.35. Fatality lower bound : 1.13. Fatality upper bound: 1.62. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age; Gender; Address; Clinical Severity. Study Type: Retrospective observational study. Sample Size: 18465. Study Population: Hubei Province as of February 27,2020 followed up to March 7, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.35. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']. "
2020-05-25,Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences,http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1,MedRxiv,,,,,,AHR=1.65,1.37,1.97,,Significant,Adjusted,Extracted,Age; Gender,Retrospective observational study,18465,"Hubei Province as of February 27,2020 followed up to March 7, 2020",N,N,"['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']",,1.65,0,0,"Date: 2020-05-25. Study: Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences. Study Link: http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=1.65. Fatality lower bound : 1.37. Fatality upper bound: 1.97. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age; Gender. Study Type: Retrospective observational study. Sample Size: 18465. Study Population: Hubei Province as of February 27,2020 followed up to March 7, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.65. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']. "
2020-05-25,Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences,http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1,MedRxiv,,,,,,AHR=1.66,1.39,1.99,,Significant,Adjusted,Extracted,Age,Retrospective observational study,18465,"Hubei Province as of February 27,2020 followed up to March 7, 2020",N,N,"['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']",,1.66,0,0,"Date: 2020-05-25. Study: Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences. Study Link: http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=1.66. Fatality lower bound : 1.39. Fatality upper bound: 1.99. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age. Study Type: Retrospective observational study. Sample Size: 18465. Study Population: Hubei Province as of February 27,2020 followed up to March 7, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.66. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']. "
2020-05-25,Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences,http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1,MedRxiv,,,,,,HR=3.25,2.71,3.89,,Significant,Not Adjusted,Extracted,,Retrospective observational study,18465,"Hubei Province as of February 27,2020 followed up to March 7, 2020",N,N,"['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']",,3.25,0,0,"Date: 2020-05-25. Study: Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences. Study Link: http://medrxiv.org/cgi/content/short/2020.05.22.20109579v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : HR=3.25. Fatality lower bound : 2.71. Fatality upper bound: 3.89. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 18465. Study Population: Hubei Province as of February 27,2020 followed up to March 7, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 3.25. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'patients', 'comorbidities', 'license', 'medrxiv']. "
2020-05-23,Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.,https://doi.org/10.1002/oby.22913,Obesity,,,,,,AOR 1.3,0.7,2.6,0.44,Not Significant,Adjusted,Extracted,"age decile, male sex, CAD, CHF, HTN, DM, hyperlipidemia, CKD, history of cancer, smoking (past or present), BMI 30 - 40 kg/m2, BMI  40 kg/m2 and race",Retrospective observational study,572,"Age < 50, New York City between March 1st and May 17th, 2020",N,Y,[],,1.3,0,0,"Date: 2020-05-23. Study: Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.. Study Link: https://doi.org/10.1002/oby.22913. Journal: Obesity. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AOR 1.3. Fatality lower bound : 0.7. Fatality upper bound: 2.6. Fatality p-value: 0.44. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: age decile, male sex, CAD, CHF, HTN, DM, hyperlipidemia, CKD, history of cancer, smoking (past or present), BMI 30 - 40 kg/m2, BMI  40 kg/m2 and race. Study Type: Retrospective observational study. Sample Size: 572. Study Population: Age < 50, New York City between March 1st and May 17th, 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 1.3. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-23,Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.,https://doi.org/10.1002/oby.22913,Obesity,,,,,,AOR 1.4,1.2,1.7,<0.01,Significant,Adjusted,Extracted,"age decile, male sex, CAD, CHF, HTN, DM, hyperlipidemia, CKD, history of cancer, smoking (past or present), BMI 30 - 40 kg/m2, BMI  40 kg/m2 and race",Retrospective observational study,2834,"Age > 50, New York City between March 1st and May 17th, 2020",N,Y,[],,1.4,0,0,"Date: 2020-05-23. Study: Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.. Study Link: https://doi.org/10.1002/oby.22913. Journal: Obesity. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AOR 1.4. Fatality lower bound : 1.2. Fatality upper bound: 1.7. Fatality p-value: <0.01. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: age decile, male sex, CAD, CHF, HTN, DM, hyperlipidemia, CKD, history of cancer, smoking (past or present), BMI 30 - 40 kg/m2, BMI  40 kg/m2 and race. Study Type: Retrospective observational study. Sample Size: 2834. Study Population: Age > 50, New York City between March 1st and May 17th, 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 1.4. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-22,Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study,https://doi.org/10.1136/bmj.m1966,BMJ,AOR=1.23,0.99,1.5,0.06,Not Significant,AHR=1.01,0.85,1.21,0.87,Not Significant,Adjusted,Extracted,Vital signs; Laboratory results,Retrospective observational study,990,"NYU Langone Health between March 1, 2020 to April 8, 2020",Y,N,"['hospital', 'patients', 'illness', 'disease', 'critical']",1.23,1.01,0,0,"Date: 2020-05-22. Study: Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. Study Link: https://doi.org/10.1136/bmj.m1966. Journal: BMJ. Severe: AOR=1.23. Severe Lower Bound: 0.99. Severe Upper Bound: 1.5. Severe p-value: 0.06. Severe Significant: Not Significant. Fatalyty : AHR=1.01. Fatality lower bound : 0.85. Fatality upper bound: 1.21. Fatality p-value: 0.87. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Vital signs; Laboratory results. Study Type: Retrospective observational study. Sample Size: 990. Study Population: NYU Langone Health between March 1, 2020 to April 8, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.23. Fatality_number: 1.01. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['hospital', 'patients', 'illness', 'disease', 'critical']. "
2020-05-22,Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET),http://medrxiv.org/cgi/content/short/2020.05.18.20103390v1?rss=1,MedRxiv,RR 1.13,1.03,1.24,,Significant,RR 1.19,1.01,1.4,,Significant,Adjusted,Extracted,"age, sex, race/ethnicity, smoker, hypertension, obesity, diabetes, chronic lung disease, cardiovascular disease, neurologic disease, renal disease, immunosuppression, hematologic disorders, and rheumatologic or autoimmune disease",Retrospective observational study,2490,"114 counties located in 14 states 113 (California, Colorado, Connecticut, Georgia, Iowa, Maryland, Michigan, Minnesota, New Mexico, New 114 York, Ohio, Oregon, Tennessee, and Utah)",Y,N,"['preprint', 'na', 'covid', 'patients', 'disease']",1.13,1.19,0,0,"Date: 2020-05-22. Study: Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Study Link: http://medrxiv.org/cgi/content/short/2020.05.18.20103390v1?rss=1. Journal: MedRxiv. Severe: RR 1.13. Severe Lower Bound: 1.03. Severe Upper Bound: 1.24. Severe p-value: nan. Severe Significant: Significant. Fatalyty : RR 1.19. Fatality lower bound : 1.01. Fatality upper bound: 1.4. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: age, sex, race/ethnicity, smoker, hypertension, obesity, diabetes, chronic lung disease, cardiovascular disease, neurologic disease, renal disease, immunosuppression, hematologic disorders, and rheumatologic or autoimmune disease. Study Type: Retrospective observational study. Sample Size: 2490. Study Population: 114 counties located in 14 states 113 (California, Colorado, Connecticut, Georgia, Iowa, Maryland, Michigan, Minnesota, New Mexico, New 114 York, Ohio, Oregon, Tennessee, and Utah). Critical Only: Y. Discharged vs Death: N.Severe_number: 1.13. Fatality_number: 1.19. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'na', 'covid', 'patients', 'disease']. "
2020-05-22,Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET),http://medrxiv.org/cgi/content/short/2020.05.18.20103390v1?rss=1,MedRxiv,RR 1.20,1.08,1.34,,Significant,RR 1.44,1.2,1.72,,Significant,Not Adjusted,Extracted,,Retrospective observational study,2490,"113 counties located in 14 states 113 (California, Colorado, Connecticut, Georgia, Iowa, Maryland, Michigan, Minnesota, New Mexico, New 114 York, Ohio, Oregon, Tennessee, and Utah)",Y,N,"['preprint', 'na', 'covid', 'patients', 'disease']",1.2,1.44,0,0,"Date: 2020-05-22. Study: Interim Analysis of Risk Factors for Severe Outcomes among a Cohort of Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Study Link: http://medrxiv.org/cgi/content/short/2020.05.18.20103390v1?rss=1. Journal: MedRxiv. Severe: RR 1.20. Severe Lower Bound: 1.08. Severe Upper Bound: 1.34. Severe p-value: nan. Severe Significant: Significant. Fatalyty : RR 1.44. Fatality lower bound : 1.2. Fatality upper bound: 1.72. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 2490. Study Population: 113 counties located in 14 states 113 (California, Colorado, Connecticut, Georgia, Iowa, Maryland, Michigan, Minnesota, New Mexico, New 114 York, Ohio, Oregon, Tennessee, and Utah). Critical Only: Y. Discharged vs Death: N.Severe_number: 1.2. Fatality_number: 1.44. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['preprint', 'na', 'covid', 'patients', 'disease']. "
2020-05-22,Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study,https://doi.org/10.1016/j.diabres.2020.108227,Diabetes Res Clin Pract,,,,,,AHR=2.80,1.01,7.8,<0.05,Significant,Adjusted,Extracted,Age,Retrospective observational study,258,"West Court of Union Hospital of Huazhong University of Science and Technology from January 29 to February 12, 2020",N,N,['redirecting'],,2.8,0,0,"Date: 2020-05-22. Study: Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study. Study Link: https://doi.org/10.1016/j.diabres.2020.108227. Journal: Diabetes Res Clin Pract. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=2.80. Fatality lower bound : 1.01. Fatality upper bound: 7.8. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age. Study Type: Retrospective observational study. Sample Size: 258. Study Population: West Court of Union Hospital of Huazhong University of Science and Technology from January 29 to February 12, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 2.8. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-05-22,Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.,https://doi.org/10.1136/bmj.m1985,BMJ,,,,,,HR=1.06,0.99,1.14,0.09,Not Significant,Adjusted,Extracted,Age; Sex: Major Comorbidity,Prospective observational study,20133,"208 acute care hospitals in England, Wales, and Scotland between 6 February and 19 April 2020",N,N,"['patients', 'hospital', 'care', 'data', 'study']",,1.06,0,0,"Date: 2020-05-22. Study: Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.. Study Link: https://doi.org/10.1136/bmj.m1985. Journal: BMJ. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : HR=1.06. Fatality lower bound : 0.99. Fatality upper bound: 1.14. Fatality p-value: 0.09. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age; Sex: Major Comorbidity. Study Type: Prospective observational study. Sample Size: 20133. Study Population: 208 acute care hospitals in England, Wales, and Scotland between 6 February and 19 April 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.06. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'hospital', 'care', 'data', 'study']. "
2020-05-22,Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.,https://doi.org/10.1002/jmv.26050,Journal of medical virology,,,,,,OR=1.97,1.67,2.31,<0.05,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,12 studies enrolling 4315 patients,"PubMed, Google scholar, Web of Science, and China National Knowledge Infrastructure (CNKI) between January 1, 2020 and April 24, 2020 without language restriction",N,N,[],,1.97,0,0,"Date: 2020-05-22. Study: Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.. Study Link: https://doi.org/10.1002/jmv.26050. Journal: Journal of medical virology. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR=1.97. Fatality lower bound : 1.67. Fatality upper bound: 2.31. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 12 studies enrolling 4315 patients. Study Population: PubMed, Google scholar, Web of Science, and China National Knowledge Infrastructure (CNKI) between January 1, 2020 and April 24, 2020 without language restriction. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.97. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-20,COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter,https://www.sciencedirect.com/science/article/pii/S001650852034703X?v=s5,Gastroenterology,OR 1.40,0.28,7.02,0.68,Not Significant,,,,,,,,,Retrospective observational study,38,"Liver transplant patients at Mount Sinai Hospital from March 18, 2020 to April 13, 2020",N,N,[],1.4,,0,0,"Date: 2020-05-20. Study: COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter. Study Link: https://www.sciencedirect.com/science/article/pii/S001650852034703X?v=s5. Journal: Gastroenterology. Severe: OR 1.40. Severe Lower Bound: 0.28. Severe Upper Bound: 7.02. Severe p-value: 0.68. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 38. Study Population: Liver transplant patients at Mount Sinai Hospital from March 18, 2020 to April 13, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 1.4. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-20,Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study,https://www.england.nhs.uk/wp-content/uploads/2020/05/valabhji-COVID-19-and-Diabetes-Paper-1.pdf,NHS England,,,,,,AOR 2.01,1.96,2.07,<0.01,Significant,Adjusted,Extracted,"age, sex, deprivation, ethnicity, region, heart disease, cerebrovascular disease, heart failure, diabetes",Retrospective observational study,61414470,"All individuals registered with a GP practice in England and alive on the 19th February; data extracted on May 11, 2020.",N,N,[],,2.01,0,0,"Date: 2020-05-20. Study: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study. Study Link: https://www.england.nhs.uk/wp-content/uploads/2020/05/valabhji-COVID-19-and-Diabetes-Paper-1.pdf. Journal: NHS England. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AOR 2.01. Fatality lower bound : 1.96. Fatality upper bound: 2.07. Fatality p-value: <0.01. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: age, sex, deprivation, ethnicity, region, heart disease, cerebrovascular disease, heart failure, diabetes. Study Type: Retrospective observational study. Sample Size: 61414470. Study Population: All individuals registered with a GP practice in England and alive on the 19th February; data extracted on May 11, 2020.. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 2.01. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-19,Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis,http://medrxiv.org/cgi/content/short/2020.05.13.20100495v1?rss=1,MedRxiv,OR=2.06,0.77,5.5,0.15,Not Significant,OR=1.89,1.07,3.36,<0.05,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,4 studies enrolling 407 patients,"PubMed from January 1 until April 19, 2020",Y,N,"['vs', 'preprint', 'yes', 'license', 'medrxiv']",2.06,1.89,0,0,"Date: 2020-05-19. Study: Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis. Study Link: http://medrxiv.org/cgi/content/short/2020.05.13.20100495v1?rss=1. Journal: MedRxiv. Severe: OR=2.06. Severe Lower Bound: 0.77. Severe Upper Bound: 5.5. Severe p-value: 0.15. Severe Significant: Not Significant. Fatalyty : OR=1.89. Fatality lower bound : 1.07. Fatality upper bound: 3.36. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 4 studies enrolling 407 patients. Study Population: PubMed from January 1 until April 19, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 2.06. Fatality_number: 1.89. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['vs', 'preprint', 'yes', 'license', 'medrxiv']. "
2020-05-19,Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19,https://www.ncbi.nlm.nih.gov/pubmed/32423368/,Otolaryngol Head Neck Surg,OR 1.60,1.06,2.41,<0.05,Significant,,,,,,,,,Retrospective observational study,486,"Ten hospitals in the Chicago metropolitan area from March 1, 2020 to April 8, 2020",Y,N,"['patients', 'intubation', 'factors', 'age', 'intubated']",1.6,,0,0,"Date: 2020-05-19. Study: Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32423368/. Journal: Otolaryngol Head Neck Surg. Severe: OR 1.60. Severe Lower Bound: 1.06. Severe Upper Bound: 2.41. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 486. Study Population: Ten hospitals in the Chicago metropolitan area from March 1, 2020 to April 8, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.6. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'intubation', 'factors', 'age', 'intubated']. "
2020-05-19,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",https://www.sciencedirect.com/science/article/pii/S0140673620311892,Lancet,,,,,,AHR=1.31,0.81,2.1,,Not Significant,Adjusted,Extracted,Age; Male sex; Symptom duration before hospital presentation; Hypertension; Chronic cardiac disease; COPD or interstitial lung disease; Diabetes; IL-6; D-dimer,Prospective observational study,257,"NewYork-Presbyterian hospitals Milstein Hospital and Allen Hospital from March 2, 2020 to April 1, 2020",N,N,[],,1.31,0,0,"Date: 2020-05-19. Study: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Study Link: https://www.sciencedirect.com/science/article/pii/S0140673620311892. Journal: Lancet. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=1.31. Fatality lower bound : 0.81. Fatality upper bound: 2.1. Fatality p-value: nan. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age; Male sex; Symptom duration before hospital presentation; Hypertension; Chronic cardiac disease; COPD or interstitial lung disease; Diabetes; IL-6; D-dimer. Study Type: Prospective observational study. Sample Size: 257. Study Population: NewYork-Presbyterian hospitals Milstein Hospital and Allen Hospital from March 2, 2020 to April 1, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.31. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-19,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",https://www.sciencedirect.com/science/article/pii/S0140673620311892,Lancet,,,,,,HR=1.65,1.11,2.44,,Significant,Not Adjusted,Extracted,,Prospective observational study,257,"NewYork-Presbyterian hospitals Milstein Hospital and Allen Hospital from March 2, 2020 to April 1, 2020",N,N,[],,1.65,0,0,"Date: 2020-05-19. Study: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Study Link: https://www.sciencedirect.com/science/article/pii/S0140673620311892. Journal: Lancet. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : HR=1.65. Fatality lower bound : 1.11. Fatality upper bound: 2.44. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Prospective observational study. Sample Size: 257. Study Population: NewYork-Presbyterian hospitals Milstein Hospital and Allen Hospital from March 2, 2020 to April 1, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.65. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-16,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York",https://www.ncbi.nlm.nih.gov/pubmed/32422233/,Metabolism,AOR=1.26,0.58,2.73,0.56,Not Significant,AOR=1.16,0.55,2.44,0.7,Not Significant,Adjusted,Extracted,Sex; Age (quartiles); BMI<25; BMI>35; Diabetes; Current/former smoker; Hyperlipidemia; Obstructive sleep apnea (additionally for mortality: Heart failure; CAD; CKD or ESRD; COPD),Retrospective observational study,200,"Montefiore Medical Center in the Bronx, New York admission from March 9, 2020 to March 22, 2020 (followed up through April 12, 2020)",Y,N,"['cases', 'clusters', 'transmission', 'community', 'covid']",1.26,1.16,0,0,"Date: 2020-05-16. Study: Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32422233/. Journal: Metabolism. Severe: AOR=1.26. Severe Lower Bound: 0.58. Severe Upper Bound: 2.73. Severe p-value: 0.56. Severe Significant: Not Significant. Fatalyty : AOR=1.16. Fatality lower bound : 0.55. Fatality upper bound: 2.44. Fatality p-value: 0.7. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Sex; Age (quartiles); BMI<25; BMI>35; Diabetes; Current/former smoker; Hyperlipidemia; Obstructive sleep apnea (additionally for mortality: Heart failure; CAD; CKD or ESRD; COPD). Study Type: Retrospective observational study. Sample Size: 200. Study Population: Montefiore Medical Center in the Bronx, New York admission from March 9, 2020 to March 22, 2020 (followed up through April 12, 2020). Critical Only: Y. Discharged vs Death: N.Severe_number: 1.26. Fatality_number: 1.16. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['cases', 'clusters', 'transmission', 'community', 'covid']. "
2020-05-16,"Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York",https://www.ncbi.nlm.nih.gov/pubmed/32422233/,Metabolism,OR=1.95,0.98,3.88,0.06,Not Significant,OR=1.76,0.91,3.4,0.09,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,200,"Montefiore Medical Center in the Bronx, New York admission from March 9, 2020 to March 22, 2020 (followed up through April 12, 2020)",Y,N,"['cases', 'clusters', 'transmission', 'community', 'covid']",1.95,1.76,0,0,"Date: 2020-05-16. Study: Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32422233/. Journal: Metabolism. Severe: OR=1.95. Severe Lower Bound: 0.98. Severe Upper Bound: 3.88. Severe p-value: 0.06. Severe Significant: Not Significant. Fatalyty : OR=1.76. Fatality lower bound : 0.91. Fatality upper bound: 3.4. Fatality p-value: 0.09. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 200. Study Population: Montefiore Medical Center in the Bronx, New York admission from March 9, 2020 to March 22, 2020 (followed up through April 12, 2020). Critical Only: Y. Discharged vs Death: N.Severe_number: 1.95. Fatality_number: 1.76. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['cases', 'clusters', 'transmission', 'community', 'covid']. "
2020-05-15,Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19,https://doi.org/10.1007/s11427-020-1732-2,Sci China Life Sci,,,,,,AHR=0.57,0.35,0.92,<0.05,Significant,Adjusted,Extracted,Hydroxychloroquine treated; Age; Gender; Hypertension; CHD; COPD; Diabetes; Body temperature; SpO2; Oxygen Therapy; Mechanical ventilation,Retrospective observational study,550,"Tongji Hospital from Feb 1, 2020 to Apr 4, 2020",N,N,"['google', 'scholar', 'article', 'author', 'hydroxychloroquine']",,0.57,0,0,"Date: 2020-05-15. Study: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Study Link: https://doi.org/10.1007/s11427-020-1732-2. Journal: Sci China Life Sci. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=0.57. Fatality lower bound : 0.35. Fatality upper bound: 0.92. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Hydroxychloroquine treated; Age; Gender; Hypertension; CHD; COPD; Diabetes; Body temperature; SpO2; Oxygen Therapy; Mechanical ventilation. Study Type: Retrospective observational study. Sample Size: 550. Study Population: Tongji Hospital from Feb 1, 2020 to Apr 4, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 0.57. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['google', 'scholar', 'article', 'author', 'hydroxychloroquine']. "
2020-05-15,Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19,https://doi.org/10.1007/s11427-020-1732-2,Sci China Life Sci,,,,,,HR=0.64,0.45,0.93,<0.05,Significant,Not Adjusted,Extracted,,Retrospective observational study,550,"Tongji Hospital from Feb 1, 2020 to Apr 4, 2020",N,N,"['google', 'scholar', 'article', 'author', 'hydroxychloroquine']",,0.64,0,0,"Date: 2020-05-15. Study: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Study Link: https://doi.org/10.1007/s11427-020-1732-2. Journal: Sci China Life Sci. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : HR=0.64. Fatality lower bound : 0.45. Fatality upper bound: 0.93. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 550. Study Population: Tongji Hospital from Feb 1, 2020 to Apr 4, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 0.64. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['google', 'scholar', 'article', 'author', 'hydroxychloroquine']. "
2020-05-15,Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France,https://www.sciencedirect.com/science/article/pii/S0040595720300949?v=s5,Therapies,OR 0.54,0.18,1.58,0.26,Not Significant,,,,,,,,,Case series,96,"Toulouse University Hospital in France between March 10, 2020 and April 21, 2020",Y,N,[],0.54,,0,0,"Date: 2020-05-15. Study: Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France. Study Link: https://www.sciencedirect.com/science/article/pii/S0040595720300949?v=s5. Journal: Therapies. Severe: OR 0.54. Severe Lower Bound: 0.18. Severe Upper Bound: 1.58. Severe p-value: 0.26. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Case series. Sample Size: 96. Study Population: Toulouse University Hospital in France between March 10, 2020 and April 21, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 0.54. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-14,"Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.",https://doi.org/10.2337/dc20-0576,Diabetes care,OR 4.28,1.78,10.28,0,,,,,,,,,,Retrospective observational study,383,"Third People’s Hospital of Shenzhen, from 11 January 2020 to 16 February 2020 (followed until 26 March 2020)",N,N,[],4.28,,0,0,"Date: 2020-05-14. Study: Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.. Study Link: https://doi.org/10.2337/dc20-0576. Journal: Diabetes care. Severe: OR 4.28. Severe Lower Bound: 1.78. Severe Upper Bound: 10.28. Severe p-value: 0. Severe Significant: nan. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 383. Study Population: Third People’s Hospital of Shenzhen, from 11 January 2020 to 16 February 2020 (followed until 26 March 2020). Critical Only: N. Discharged vs Death: N.Severe_number: 4.28. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-14,"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study",https://doi.org/10.2337/dc20-0598,Diabetes care,,,,,,OR 1.13,4.17,0.02,,Significant,Not Adjusted,Calculated,,Retrospective observational study,153,Renmin Hospital of Wuhan University and Zhongnan Hospital of Wuhan University from 1 January 2020 to 8 March 2020,N,Y,[],,1.13,0,1,"Date: 2020-05-14. Study: Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Study Link: https://doi.org/10.2337/dc20-0598. Journal: Diabetes care. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.13. Fatality lower bound : 4.17. Fatality upper bound: 0.02. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 153. Study Population: Renmin Hospital of Wuhan University and Zhongnan Hospital of Wuhan University from 1 January 2020 to 8 March 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 1.13. Severe_outside_bounds: 0. Fatality_outside_bounds: 1. Key word: []. "
2020-05-14,Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.,https://doi.org/10.2337/dc20-0660,Diabetes care,OR=2.21,1.5,3.26,,Significant,OR=2.51,1.53,4.13,,Significant,Not Adjusted,Extracted,,Retrospective observational study,904,Central Hospital of Wuhan from 1 January 2020 to 17 March 2020,N,Y,[],2.21,2.51,0,0,Date: 2020-05-14. Study: Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.. Study Link: https://doi.org/10.2337/dc20-0660. Journal: Diabetes care. Severe: OR=2.21. Severe Lower Bound: 1.5. Severe Upper Bound: 3.26. Severe p-value: nan. Severe Significant: Significant. Fatalyty : OR=2.51. Fatality lower bound : 1.53. Fatality upper bound: 4.13. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 904. Study Population: Central Hospital of Wuhan from 1 January 2020 to 17 March 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: 2.21. Fatality_number: 2.51. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. 
2020-05-14,Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico,http://medrxiv.org/cgi/content/short/2020.05.11.20098145v1?rss=1,MedRxiv,,,,,,OR 2.70,3.58,0.0,,Significant,Not Adjusted,Calculated,,Retrospective observational study,9946,"Epidemiological Surveillance System for Viral Respiratory Diseases of the Mexican Ministry of Health (Secretaría de Salud, SS) on April 23rd, 2020",N,N,"['preprint', 'risk', 'obesity', 'hypertension', 'diabetes']",,2.7,0,1,"Date: 2020-05-14. Study: Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico. Study Link: http://medrxiv.org/cgi/content/short/2020.05.11.20098145v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 2.70. Fatality lower bound : 3.58. Fatality upper bound: 0.0. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 9946. Study Population: Epidemiological Surveillance System for Viral Respiratory Diseases of the Mexican Ministry of Health (Secretaría de Salud, SS) on April 23rd, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 2.7. Severe_outside_bounds: 0. Fatality_outside_bounds: 1. Key word: ['preprint', 'risk', 'obesity', 'hypertension', 'diabetes']. "
2020-05-14,The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis,http://medrxiv.org/cgi/content/short/2020.05.10.20097253v1?rss=1,MedRxiv,,,,,,RR 1.37,0.85,2.2,,Not Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,12 studies,"PubMed (MEDLINE), OVID (MEDLINE, HEALTHSTAR), SCOPUS, and medrxiv.org from October 1, 2019 to May 1, 2023",N,N,"['mortality', 'preprint', 'risk', 'disease', 'studies']",,1.37,0,0,"Date: 2020-05-14. Study: The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. Study Link: http://medrxiv.org/cgi/content/short/2020.05.10.20097253v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : RR 1.37. Fatality lower bound : 0.85. Fatality upper bound: 2.2. Fatality p-value: nan. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 12 studies. Study Population: PubMed (MEDLINE), OVID (MEDLINE, HEALTHSTAR), SCOPUS, and medrxiv.org from October 1, 2019 to May 1, 2023. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.37. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['mortality', 'preprint', 'risk', 'disease', 'studies']. "
2020-05-14,Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy,https://www.ncbi.nlm.nih.gov/pubmed/32383763/,Eur Heart J,,,,,,OR 3.47,1.02,11.82,0.05,Significant,Not Adjusted,Calculated,,Retrospective observational study,99,"Civil Hospitals of Brescia, Lombardy, Italy, between 4 March and 25 March 2020",N,N,"['patients', 'cardiac', 'disease', 'higher', 'without']",,3.47,0,0,"Date: 2020-05-14. Study: Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32383763/. Journal: Eur Heart J. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 3.47. Fatality lower bound : 1.02. Fatality upper bound: 11.82. Fatality p-value: 0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 99. Study Population: Civil Hospitals of Brescia, Lombardy, Italy, between 4 March and 25 March 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 3.47. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'cardiac', 'disease', 'higher', 'without']. "
2020-05-13,"Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China",https://www.ncbi.nlm.nih.gov/pubmed/32351037/,Transbound Emerg Dis,OR=1.1,0.3,3.6,0.88,Not Significant,,,,,,,,,Retrospective observational study,333,"Center for Disease Control and Prevention in Shanghai as of February 19, 2020",N,N,"['cases', 'confirmed', 'shanghai', 'onset', 'disease']",1.1,,0,0,"Date: 2020-05-13. Study: Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32351037/. Journal: Transbound Emerg Dis. Severe: OR=1.1. Severe Lower Bound: 0.3. Severe Upper Bound: 3.6. Severe p-value: 0.88. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 333. Study Population: Center for Disease Control and Prevention in Shanghai as of February 19, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 1.1. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['cases', 'confirmed', 'shanghai', 'onset', 'disease']. "
2020-05-12,Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.,https://doi.org/10.1001/jamainternmed.2020.2033,JAMA internal medicine,OR 4.26,2.71,6.69,0,Significant,,,,,,,,,Retrospective observational study,1590,"China National Health Commission between November 21, 2019 and January 31, 2020",Y,N,[],4.26,,0,0,"Date: 2020-05-12. Study: Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.. Study Link: https://doi.org/10.1001/jamainternmed.2020.2033. Journal: JAMA internal medicine. Severe: OR 4.26. Severe Lower Bound: 2.71. Severe Upper Bound: 6.69. Severe p-value: 0. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 1590. Study Population: China National Health Commission between November 21, 2019 and January 31, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 4.26. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-01,A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis Q1 patients with SARS-CoV-2 infection,http://doi.org/10.1016/j.kint.2020.04.030,Kidney International,OR 1.7,0.75,3.9,0.21,Not Significant,OR 1.7,0.69,4.2,0.25,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,94,"Brescia Renal COVID Task Force from March 1, 2020 to April 3, 2020",Y,N,['redirecting'],1.7,1.7,0,0,"Date: 2020-05-01. Study: A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis Q1 patients with SARS-CoV-2 infection. Study Link: http://doi.org/10.1016/j.kint.2020.04.030. Journal: Kidney International. Severe: OR 1.7. Severe Lower Bound: 0.75. Severe Upper Bound: 3.9. Severe p-value: 0.21. Severe Significant: Not Significant. Fatalyty : OR 1.7. Fatality lower bound : 0.69. Fatality upper bound: 4.2. Fatality p-value: 0.25. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 94. Study Population: Brescia Renal COVID Task Force from March 1, 2020 to April 3, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.7. Fatality_number: 1.7. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-05-12,"Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study",https://www.ncbi.nlm.nih.gov/pubmed/32383809/,J Am Geriatr Soc,,,,,,OR 1.18,0.64,2.2,0.59,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,244,"Sino-French New City Branch of Tongji Hospital from Jan 29, 2020 to Mar 5, 2020",N,Y,"['older', 'patients', 'risk', 'p', 'factors']",,1.18,0,0,"Date: 2020-05-12. Study: Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32383809/. Journal: J Am Geriatr Soc. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.18. Fatality lower bound : 0.64. Fatality upper bound: 2.2. Fatality p-value: 0.59. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 244. Study Population: Sino-French New City Branch of Tongji Hospital from Jan 29, 2020 to Mar 5, 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 1.18. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['older', 'patients', 'risk', 'p', 'factors']. "
2020-05-11,Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea,http://medrxiv.org/cgi/content/short/2020.05.08.20095174v1?rss=1,MedRxiv,OR 3.92,3.04,5.06,0,Significant,,,,,,,,,Retrospective observational study,5172,"The insurance claims database of the HIRA of South Korea through April 8, 2020",Y,N,"['disease', 'preprint', 'license', 'medrxiv', 'orr']",3.92,,0,0,"Date: 2020-05-11. Study: Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea. Study Link: http://medrxiv.org/cgi/content/short/2020.05.08.20095174v1?rss=1. Journal: MedRxiv. Severe: OR 3.92. Severe Lower Bound: 3.04. Severe Upper Bound: 5.06. Severe p-value: 0. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 5172. Study Population: The insurance claims database of the HIRA of South Korea through April 8, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 3.92. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['disease', 'preprint', 'license', 'medrxiv', 'orr']. "
2020-05-11,Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19,https://doi.org/10.1186/s12933-020-01035-2,Cardiovasc Diabetol,OR 2.64,1.27,5.68,0.01,Significant,,,,,,,,,Retrospective observational study,151,"Tongji Hospital of Huazhong University of Science and Technology in Wuhan, China from Jan 12 2020, to Feb 13 2020",N,N,"['patients', 'tyg', 'index', 'severe', 'disease']",2.64,,0,0,"Date: 2020-05-11. Study: Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19. Study Link: https://doi.org/10.1186/s12933-020-01035-2. Journal: Cardiovasc Diabetol. Severe: OR 2.64. Severe Lower Bound: 1.27. Severe Upper Bound: 5.68. Severe p-value: 0.01. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 151. Study Population: Tongji Hospital of Huazhong University of Science and Technology in Wuhan, China from Jan 12 2020, to Feb 13 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 2.64. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'tyg', 'index', 'severe', 'disease']. "
2020-05-11,Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pubmed/32391877/,Eur Heart J,,,,,,AHR=1.04,0.44,2.45,0.93,Not Significant,Adjusted,Extracted,Lab values,Retrospective observational study,671,"Renmin Hospital of Wuhan University, located in Wuhan, Hubei Province, from February 18, 2020 through February 23, 2020",N,N,"['covid', 'patients', 'clinical', 'md', 'facc']",,1.04,0,0,"Date: 2020-05-11. Study: Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32391877/. Journal: Eur Heart J. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=1.04. Fatality lower bound : 0.44. Fatality upper bound: 2.45. Fatality p-value: 0.93. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Lab values. Study Type: Retrospective observational study. Sample Size: 671. Study Population: Renmin Hospital of Wuhan University, located in Wuhan, Hubei Province, from February 18, 2020 through February 23, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.04. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['covid', 'patients', 'clinical', 'md', 'facc']. "
2020-05-11,Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019,https://www.ncbi.nlm.nih.gov/pubmed/32391877/,Eur Heart J,,,,,,AHR=1.16,0.47,2.85,0.75,Not Significant,Adjusted,Extracted,Senior age; Lab values,Retrospective observational study,671,"Renmin Hospital of Wuhan University, located in Wuhan, Hubei Province, from February 18, 2020 through February 23, 2020",N,N,"['covid', 'patients', 'clinical', 'md', 'facc']",,1.16,0,0,"Date: 2020-05-11. Study: Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32391877/. Journal: Eur Heart J. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR=1.16. Fatality lower bound : 0.47. Fatality upper bound: 2.85. Fatality p-value: 0.75. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Senior age; Lab values. Study Type: Retrospective observational study. Sample Size: 671. Study Population: Renmin Hospital of Wuhan University, located in Wuhan, Hubei Province, from February 18, 2020 through February 23, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.16. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['covid', 'patients', 'clinical', 'md', 'facc']. "
2020-05-10,COVID-19 in solid organ transplant recipients: Initial report from the US epicenter,https://www.ncbi.nlm.nih.gov/pubmed/32330343/,Am J Transplant,OR 1.44,0.58,3.55,0.43,Not Significant,,,,,,,,,Retrospective observational study,90,"Columbia University Irving Medical Center (CUIMC) and Weill Cornell Medicine (WCM) between March 13, 2020 and April 3, 2020",Y,N,"['recipients', 'transplant', 'patients', 'solid', 'organ']",1.44,,0,0,"Date: 2020-05-10. Study: COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32330343/. Journal: Am J Transplant. Severe: OR 1.44. Severe Lower Bound: 0.58. Severe Upper Bound: 3.55. Severe p-value: 0.43. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 90. Study Population: Columbia University Irving Medical Center (CUIMC) and Weill Cornell Medicine (WCM) between March 13, 2020 and April 3, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.44. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['recipients', 'transplant', 'patients', 'solid', 'organ']. "
2020-05-10,Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence,http://medrxiv.org/cgi/content/short/2020.05.06.20093351v1?rss=1,MedRxiv,AHR=1.59,1.03,2.45,,Significant,AHR=2.84,1.01,8.01,,Significant,Adjusted,Extracted,Severity: Age; Smoking: Fatality: Age; Other comorbidities; Clinical biomarkers,Expert review,"severity: 1590, fatality: 416","Pennington et al., Web of Science, Google Scholar, WHO, MEDLINE, CDC of the USA, Europe, and China",Y,N,"['covid', 'studies', 'preprint', 'patients', 'risk']",1.59,2.84,0,0,"Date: 2020-05-10. Study: Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence. Study Link: http://medrxiv.org/cgi/content/short/2020.05.06.20093351v1?rss=1. Journal: MedRxiv. Severe: AHR=1.59. Severe Lower Bound: 1.03. Severe Upper Bound: 2.45. Severe p-value: nan. Severe Significant: Significant. Fatalyty : AHR=2.84. Fatality lower bound : 1.01. Fatality upper bound: 8.01. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Severity: Age; Smoking: Fatality: Age; Other comorbidities; Clinical biomarkers. Study Type: Expert review. Sample Size: severity: 1590, fatality: 416. Study Population: Pennington et al., Web of Science, Google Scholar, WHO, MEDLINE, CDC of the USA, Europe, and China. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.59. Fatality_number: 2.84. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['covid', 'studies', 'preprint', 'patients', 'risk']. "
2020-05-10,COVID-19 in solid organ transplant recipients: Initial report from the US epicenter,https://www.ncbi.nlm.nih.gov/pubmed/32330343/,Am J Transplant,OR 1.44,0.58,3.55,0.43,Not Significant,,,,,,,,,Retrospective observational study,90,"Columbia University Irving Medical Center (CUIMC) and Weill Cornell Medicine (WCM) between March 13, 2020 and April 3, 2020",Y,N,"['recipients', 'transplant', 'patients', 'solid', 'organ']",1.44,,0,0,"Date: 2020-05-10. Study: COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32330343/. Journal: Am J Transplant. Severe: OR 1.44. Severe Lower Bound: 0.58. Severe Upper Bound: 3.55. Severe p-value: 0.43. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 90. Study Population: Columbia University Irving Medical Center (CUIMC) and Weill Cornell Medicine (WCM) between March 13, 2020 and April 3, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.44. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['recipients', 'transplant', 'patients', 'solid', 'organ']. "
2020-05-10,Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.,http://medrxiv.org/cgi/content/short/2020.05.05.20092015v1?rss=1,MedRxiv,,,,,,OR 1.02,2.61,0.04,,Significant,Not Adjusted,Calculated,,Retrospective observational study,441,"Parma, Northern Italy, from March 5 to March 31, 2024",N,N,"['e', 'h', 'r', 'p', 'preprint']",,1.02,0,1,"Date: 2020-05-10. Study: Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19.. Study Link: http://medrxiv.org/cgi/content/short/2020.05.05.20092015v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.02. Fatality lower bound : 2.61. Fatality upper bound: 0.04. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 441. Study Population: Parma, Northern Italy, from March 5 to March 31, 2024. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.02. Severe_outside_bounds: 0. Fatality_outside_bounds: 1. Key word: ['e', 'h', 'r', 'p', 'preprint']. "
2020-05-07,Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis,https://doi.org/10.1016/j.pcad.2020.05.001,Progress in Cardiovascular Disease,OR 3.02,2.07,4.42,,Significant,,,,,,,,,Systematic review and meta-analysis,11 studies,"MEDLINE, Embase, Cochrane Database of Systematic Reviews, Scopus, and Web of Science as well as preprint servers from December 2019 through April 10, 2020",Y,N,['redirecting'],3.02,,0,0,"Date: 2020-05-07. Study: Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis. Study Link: https://doi.org/10.1016/j.pcad.2020.05.001. Journal: Progress in Cardiovascular Disease. Severe: OR 3.02. Severe Lower Bound: 2.07. Severe Upper Bound: 4.42. Severe p-value: nan. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 11 studies. Study Population: MEDLINE, Embase, Cochrane Database of Systematic Reviews, Scopus, and Web of Science as well as preprint servers from December 2019 through April 10, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 3.02. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-05-07,OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.,http://medrxiv.org/cgi/content/short/2020.05.06.20092999v1?rss=1,MedRxiv,,,,,,AHR 1.50,1.4,1.6,,Significant,Adjusted,Extracted,"age, gender, obesity, smoking status, diabetes, cancer, hematological malignancy, asthma, chronic respiratory disease, heart disease, hypertension, chronic liver disease, stroke or dementia, other neurological disease, reduced kidney function, organ transplant, spleen disease, rheumatoid arthritis/lupus/psoriasis, immunosuppression",Retrospective observational study,"17,425,445","TPP general practice in England from February 1 to April 25, 2020.",N,N,"['risk', 'covid', 'data', 'preprint', 'medrxiv']",,1.5,0,0,"Date: 2020-05-07. Study: OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.. Study Link: http://medrxiv.org/cgi/content/short/2020.05.06.20092999v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : AHR 1.50. Fatality lower bound : 1.4. Fatality upper bound: 1.6. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: age, gender, obesity, smoking status, diabetes, cancer, hematological malignancy, asthma, chronic respiratory disease, heart disease, hypertension, chronic liver disease, stroke or dementia, other neurological disease, reduced kidney function, organ transplant, spleen disease, rheumatoid arthritis/lupus/psoriasis, immunosuppression. Study Type: Retrospective observational study. Sample Size: 17,425,445. Study Population: TPP general practice in England from February 1 to April 25, 2020.. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.5. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['risk', 'covid', 'data', 'preprint', 'medrxiv']. "
2020-05-01,"Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2024",http://doi.org/10.1101/2020.05.01.20087123,medrxiv,,,,,,OR 1.49,0.84,2.65,0.18,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,279,"Parma 12 University Hospital, Parma, Italy from Mar 05, 2020 to Mar 15, 2020",N,Y,[],,1.49,0,0,"Date: 2020-05-01. Study: Lung disease severity, Coronary Artery Calcium, Coronary inflammation and Mortality in Coronavirus Disease 2024. Study Link: http://doi.org/10.1101/2020.05.01.20087123. Journal: medrxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.49. Fatality lower bound : 0.84. Fatality upper bound: 2.65. Fatality p-value: 0.18. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 279. Study Population: Parma 12 University Hospital, Parma, Italy from Mar 05, 2020 to Mar 15, 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 1.49. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-05-06,Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort,https://doi.org/10.1101/2020.05.01.20087932,MedRxiv,,,,,,OR 1.68,0.94,3.01,0.08,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,217,"Montefiore Medical Center/University Hospital for Albert Einstein College of Medicine, Moses Campus between March 20th to March 31st 2020",N,Y,"['author', 'medicine', 'new', 'york', 'find']",,1.68,0,0,"Date: 2020-05-06. Study: Correlation of coagulation parameters with clinical outcomes in Coronavirus-19 affected minorities in United States: Observational cohort. Study Link: https://doi.org/10.1101/2020.05.01.20087932. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.68. Fatality lower bound : 0.94. Fatality upper bound: 3.01. Fatality p-value: 0.08. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 217. Study Population: Montefiore Medical Center/University Hospital for Albert Einstein College of Medicine, Moses Campus between March 20th to March 31st 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 1.68. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'medicine', 'new', 'york', 'find']. "
2020-05-06,Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis,https://doi.org/10.1016/j.dsx.2020.04.044,Diabetes and Metabolic Syndrome: Clinical Research and Reviews,OR 2.75,2.09,3.62,,Significant,OR 1.90,1.37,2.64,,Significant,Not Adjusted,Extracted,,Systematic review and meta-analysis,"33 studies, 16003 patients","PubMed from Feb 7, 2020 to Apr 17, 2020",N,N,['redirecting'],2.75,1.9,0,0,"Date: 2020-05-06. Study: Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Study Link: https://doi.org/10.1016/j.dsx.2020.04.044. Journal: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. Severe: OR 2.75. Severe Lower Bound: 2.09. Severe Upper Bound: 3.62. Severe p-value: nan. Severe Significant: Significant. Fatalyty : OR 1.90. Fatality lower bound : 1.37. Fatality upper bound: 2.64. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 33 studies, 16003 patients. Study Population: PubMed from Feb 7, 2020 to Apr 17, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 2.75. Fatality_number: 1.9. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-05-05,Pre-Existing Characteristics Associated with Covid-19 Illness Severity,https://doi.org/10.1101/2020.04.29.20084533,MedRxiv,AOR 1.77,1.03,3.03,<0.05,Significant,,,,,,,,"Age, Gender, African American race, Hispanic ethnicity, Obesity, Hypertension, Diabetes Mellitus, Elixhauser comorbidity score, Prior myocardial infarcion or heart failure, Prior COPD or asthma, ACE inhibitor use, Angiotensin receptor blocker use",Retrospective observational study,442,"Cedars-Sinai Health System includes Cedars-Sinai Medical Center (CSMC), Marina Del Rey Hospital (MDRH), and affiliated clinics from Feb 26, 2020 to Mar 21, 2020",Y,N,"['author', 'md', 'find', 'center', 'medical']",1.77,,0,0,"Date: 2020-05-05. Study: Pre-Existing Characteristics Associated with Covid-19 Illness Severity. Study Link: https://doi.org/10.1101/2020.04.29.20084533. Journal: MedRxiv. Severe: AOR 1.77. Severe Lower Bound: 1.03. Severe Upper Bound: 3.03. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: Age, Gender, African American race, Hispanic ethnicity, Obesity, Hypertension, Diabetes Mellitus, Elixhauser comorbidity score, Prior myocardial infarcion or heart failure, Prior COPD or asthma, ACE inhibitor use, Angiotensin receptor blocker use. Study Type: Retrospective observational study. Sample Size: 442. Study Population: Cedars-Sinai Health System includes Cedars-Sinai Medical Center (CSMC), Marina Del Rey Hospital (MDRH), and affiliated clinics from Feb 26, 2020 to Mar 21, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.77. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'md', 'find', 'center', 'medical']. "
2020-05-05,Pre-Existing Characteristics Associated with Covid-19 Illness Severity,https://doi.org/10.1101/2020.04.29.20084533,MedRxiv,AOR 2.25,1.41,3.57,<0.05,Significant,,,,,,,,"Age, Gender",Retrospective observational study,442,"Cedars-Sinai Health System includes Cedars-Sinai Medical Center (CSMC), Marina Del Rey Hospital (MDRH), and affiliated clinics from Feb 26, 2020 to Mar 21, 2020",Y,N,"['author', 'md', 'find', 'center', 'medical']",2.25,,0,0,"Date: 2020-05-05. Study: Pre-Existing Characteristics Associated with Covid-19 Illness Severity. Study Link: https://doi.org/10.1101/2020.04.29.20084533. Journal: MedRxiv. Severe: AOR 2.25. Severe Lower Bound: 1.41. Severe Upper Bound: 3.57. Severe p-value: <0.05. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: Age, Gender. Study Type: Retrospective observational study. Sample Size: 442. Study Population: Cedars-Sinai Health System includes Cedars-Sinai Medical Center (CSMC), Marina Del Rey Hospital (MDRH), and affiliated clinics from Feb 26, 2020 to Mar 21, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 2.25. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'md', 'find', 'center', 'medical']. "
2020-05-05,Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study,http://medrxiv.org/cgi/content/short/2020.04.29.20085415v1?rss=1,MedRxiv,OR 0.77,0.34,1.71,0.51,Not Significant,,,,,,,,,Retrospective observational study,106,"Huoshenshan Hospital from Feb 4, 2020 to Apr 14, 2020",N,N,"['patients', 'preprint', 'group', 'severe', 'neurological']",0.77,,0,0,"Date: 2020-05-05. Study: Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study. Study Link: http://medrxiv.org/cgi/content/short/2020.04.29.20085415v1?rss=1. Journal: MedRxiv. Severe: OR 0.77. Severe Lower Bound: 0.34. Severe Upper Bound: 1.71. Severe p-value: 0.51. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 106. Study Population: Huoshenshan Hospital from Feb 4, 2020 to Apr 14, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 0.77. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'preprint', 'group', 'severe', 'neurological']. "
2020-05-05,Risk Factors of the Severity of COVID-19: A Meta-Analysis,https://doi.org/10.1101/2020.04.30.20086744,MedRxiv,RR=1.57,1.25,1.98,,Significant,,,,,,,,,Systematic review and meta-analysis,"10 Studies, 2272 Patients","PubMed, Google Scholar, EMBASE, and Cochrane Library from Apr 2, 2020 to Apr 18, 2020",N,N,"['medicine', 'risk', 'factors', 'severity', 'author']",1.57,,0,0,"Date: 2020-05-05. Study: Risk Factors of the Severity of COVID-19: A Meta-Analysis. Study Link: https://doi.org/10.1101/2020.04.30.20086744. Journal: MedRxiv. Severe: RR=1.57. Severe Lower Bound: 1.25. Severe Upper Bound: 1.98. Severe p-value: nan. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 10 Studies, 2272 Patients. Study Population: PubMed, Google Scholar, EMBASE, and Cochrane Library from Apr 2, 2020 to Apr 18, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 1.57. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['medicine', 'risk', 'factors', 'severity', 'author']. "
2020-05-04,Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes,https://doi.org/10.1101/2020.04.28.20075788,MedRxiv,,,,,,OR 1.19,1.72,0.0,,Significant,Not Adjusted,Calculated,,Retrospective observational study,3273,Mount Sinai Health System from 2/24/2020 to 4/15/2020,N,N,"['author', 'medicine', 'find', 'mount', 'sinai']",,1.19,0,1,"Date: 2020-05-04. Study: Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes. Study Link: https://doi.org/10.1101/2020.04.28.20075788. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.19. Fatality lower bound : 1.72. Fatality upper bound: 0.0. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 3273. Study Population: Mount Sinai Health System from 2/24/2020 to 4/15/2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.19. Severe_outside_bounds: 0. Fatality_outside_bounds: 1. Key word: ['author', 'medicine', 'find', 'mount', 'sinai']. "
2020-05-03,Systematic investigations of COVID-19 in 283 cancer patients,http://medrxiv.org/cgi/content/short/2020.04.28.20083246v1?rss=1,MedRxiv,OR=0.42,0.16,1.13,0.09,Not Significant,,,,,,,,,Retrospective observational study,283,"Data of consecutive cancer patients admitted to 33 designated hospitals for COVID-19 in Hubei province, China from December 17, 2019 to March 18, 2020",Y,N,"['patients', 'cancer', 'vs', 'preprint', 'china']",0.42,,0,0,"Date: 2020-05-03. Study: Systematic investigations of COVID-19 in 283 cancer patients. Study Link: http://medrxiv.org/cgi/content/short/2020.04.28.20083246v1?rss=1. Journal: MedRxiv. Severe: OR=0.42. Severe Lower Bound: 0.16. Severe Upper Bound: 1.13. Severe p-value: 0.09. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 283. Study Population: Data of consecutive cancer patients admitted to 33 designated hospitals for COVID-19 in Hubei province, China from December 17, 2019 to March 18, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 0.42. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'cancer', 'vs', 'preprint', 'china']. "
2020-05-01,Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea,https://www.sciencedirect.com/science/article/pii/S0007091220303019,British Journal of Anaesthesia,OR 1.02,0.47,2.19,0.97,Not significant,,,,,,,,,Retrospective observational study,124,New York City,Y,N,[],1.02,,0,0,Date: 2020-05-01. Study: Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea. Study Link: https://www.sciencedirect.com/science/article/pii/S0007091220303019. Journal: British Journal of Anaesthesia. Severe: OR 1.02. Severe Lower Bound: 0.47. Severe Upper Bound: 2.19. Severe p-value: 0.97. Severe Significant: Not significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 124. Study Population: New York City. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.02. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. 
2020-05-01,"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19",https://www.ncbi.nlm.nih.gov/pubmed/32356626/,N Engl J Med,,,,,,OR 1.13,1.79,0.0,,Significant,Not Adjusted,Calculated,,Retrospective observational study,8910,"169 hospitals located in 11 countries in Asia, Europe, and North America from Dec 20, 2019 to March 15, 2020",N,N,"['disease', 'among', 'vs', 'odds', 'ratio']",,1.13,0,1,"Date: 2020-05-01. Study: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32356626/. Journal: N Engl J Med. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.13. Fatality lower bound : 1.79. Fatality upper bound: 0.0. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 8910. Study Population: 169 hospitals located in 11 countries in Asia, Europe, and North America from Dec 20, 2019 to March 15, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.13. Severe_outside_bounds: 0. Fatality_outside_bounds: 1. Key word: ['disease', 'among', 'vs', 'odds', 'ratio']. "
2020-04-30,"Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192564/,Critical Care,,,,,,OR 4.88,1.31,18.18,0.02,Significant,Not Adjusted,Calculated,,Retrospective observational study,107,"Zhongnan Hospital of Wuhan University and Xishui People’s Hospital up to Feb 10, 2020",N,Y,[],,4.88,0,0,"Date: 2020-04-30. Study: Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Study Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192564/. Journal: Critical Care. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 4.88. Fatality lower bound : 1.31. Fatality upper bound: 18.18. Fatality p-value: 0.02. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 107. Study Population: Zhongnan Hospital of Wuhan University and Xishui People’s Hospital up to Feb 10, 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 4.88. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-30,Association of Obesity with Disease Severity among Patients with COVIDâ€19,https://doi.org/10.1002/oby.22859,Obesity (Silver Spring),AOR=1.91,0.71,5.19,0.2,Not Significant,,,,,,,,Age; Race; Gender; BMI; Diabetes; Hypertension; Heart disease; Lung disease,Retrospective observational study,103,"Rhode Island Hospital, The Miriam Hospital, or Newport Hospital, in Rhode Island, USA, between February 17th and April 5th, 2020",Y,N,[],1.91,,0,0,"Date: 2020-04-30. Study: Association of Obesity with Disease Severity among Patients with COVIDâ€19. Study Link: https://doi.org/10.1002/oby.22859. Journal: Obesity (Silver Spring). Severe: AOR=1.91. Severe Lower Bound: 0.71. Severe Upper Bound: 5.19. Severe p-value: 0.2. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: Age; Race; Gender; BMI; Diabetes; Hypertension; Heart disease; Lung disease. Study Type: Retrospective observational study. Sample Size: 103. Study Population: Rhode Island Hospital, The Miriam Hospital, or Newport Hospital, in Rhode Island, USA, between February 17th and April 5th, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 1.91. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-30,Association of Obesity with Disease Severity among Patients with COVIDâ€19,https://doi.org/10.1002/oby.22859,Obesity (Silver Spring),OR=2.26,1.0,5.11,0.05,Not Significant,,,,,,,,,Retrospective observational study,103,"Rhode Island Hospital, The Miriam Hospital, or Newport Hospital, in Rhode Island, USA, between February 17th and April 5th, 2020",Y,N,[],2.26,,0,0,"Date: 2020-04-30. Study: Association of Obesity with Disease Severity among Patients with COVIDâ€19. Study Link: https://doi.org/10.1002/oby.22859. Journal: Obesity (Silver Spring). Severe: OR=2.26. Severe Lower Bound: 1.0. Severe Upper Bound: 5.11. Severe p-value: 0.05. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 103. Study Population: Rhode Island Hospital, The Miriam Hospital, or Newport Hospital, in Rhode Island, USA, between February 17th and April 5th, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 2.26. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-29,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",doi.org/10.1101/2020.04.24.20078063,medrxiv,HR 0.71,0.26,1.95,0.38,Not Significant,,,,,,,,,Prospective observational study,114,"Union Hospital from January 23, 2020 to February 22, 2020",Y,N,[],0.71,,0,0,"Date: 2020-04-29. Study: Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China. Study Link: doi.org/10.1101/2020.04.24.20078063. Journal: medrxiv. Severe: HR 0.71. Severe Lower Bound: 0.26. Severe Upper Bound: 1.95. Severe p-value: 0.38. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Prospective observational study. Sample Size: 114. Study Population: Union Hospital from January 23, 2020 to February 22, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 0.71. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-29,"Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China",10.1101/2020.04.24.20078063,medrxiv,AHR 0.62,0.22,1.73,0.36,Not Significant,,,,,,,,,Prospective observational study,114,"Union Hospital from January 23, 2020 to February 22, 2020",Y,N,[],0.62,,0,0,"Date: 2020-04-29. Study: Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China. Study Link: 10.1101/2020.04.24.20078063. Journal: medrxiv. Severe: AHR 0.62. Severe Lower Bound: 0.22. Severe Upper Bound: 1.73. Severe p-value: 0.36. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Prospective observational study. Sample Size: 114. Study Population: Union Hospital from January 23, 2020 to February 22, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 0.62. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-29,Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection,https://doi.org/10.1101/2020.04.24.20078006,medrxiv,OR 2.01,1.35,2.98,<0.01,,,,,,,,,,Retrospective observational study,708,UK NHS hospital from 1st March to 5th April 2020,Y,N,"['author', 'london', 'research', 'find', 'uk']",2.01,,0,0,"Date: 2020-04-29. Study: Supplementing the National Early Warning Score (NEWS2) for anticipating early deterioration among patients with COVID-19 infection. Study Link: https://doi.org/10.1101/2020.04.24.20078006. Journal: medrxiv. Severe: OR 2.01. Severe Lower Bound: 1.35. Severe Upper Bound: 2.98. Severe p-value: <0.01. Severe Significant: nan. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 708. Study Population: UK NHS hospital from 1st March to 5th April 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 2.01. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'london', 'research', 'find', 'uk']. "
2020-04-29,"Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.",https://doi.org/10.1101/2020.04.24.20077875,medrxiv,AOR: 1.2,0.64,2.24,0.57,Not Significant,,,,,,,,,Retrospective observational study,610,"14 hospitals in Zhejiang province, China between Jan 10 and Feb 28, 2020 and confirmed diagnosis of Covid-19 infection were included",N,N,"['author', 'find', 'ningbo', 'hospital', 'university']",1.2,,0,0,"Date: 2020-04-29. Study: Role of Drugs Affecting the Renin-Angiotensin-Aldosterone System on Susceptibility and Severity of COVID-19: A Large Case-Control Study from Zheijang Province, China.. Study Link: https://doi.org/10.1101/2020.04.24.20077875. Journal: medrxiv. Severe: AOR: 1.2. Severe Lower Bound: 0.64. Severe Upper Bound: 2.24. Severe p-value: 0.57. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 610. Study Population: 14 hospitals in Zhejiang province, China between Jan 10 and Feb 28, 2020 and confirmed diagnosis of Covid-19 infection were included. Critical Only: N. Discharged vs Death: N.Severe_number: 1.2. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'find', 'ningbo', 'hospital', 'university']. "
2020-04-28,Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection,https://doi.org/10.1101/2020.04.23.20076935,medrxiv,OR 4.42,1.54,12.63,0.01,Significant,,,,,,,,,Retrospective observational study,207,"Stanford University Hospital and Clinics from March 03, 2020 to April 7, 2020",Y,N,"['author', 'medicine', 'find', 'stanford', 'search']",4.42,,0,0,"Date: 2020-04-28. Study: Association of Digestive Symptoms and Hospitalization in Patients with SARS-CoV-2 Infection. Study Link: https://doi.org/10.1101/2020.04.23.20076935. Journal: medrxiv. Severe: OR 4.42. Severe Lower Bound: 1.54. Severe Upper Bound: 12.63. Severe p-value: 0.01. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 207. Study Population: Stanford University Hospital and Clinics from March 03, 2020 to April 7, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 4.42. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'medicine', 'find', 'stanford', 'search']. "
2020-04-28,"Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China",https://doi.org/10.1016/j.jcv.2020.104392,Journal of Clinical Virology,OR 17.6,4.84,63.98,<0.01,,,,,,,,,,Retrospective observational study,111,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from January 13 to February 16 in 2020",Y,N,['redirecting'],17.6,,0,0,"Date: 2020-04-28. Study: Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. Study Link: https://doi.org/10.1016/j.jcv.2020.104392. Journal: Journal of Clinical Virology. Severe: OR 17.6. Severe Lower Bound: 4.84. Severe Upper Bound: 63.98. Severe p-value: <0.01. Severe Significant: nan. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 111. Study Population: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from January 13 to February 16 in 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 17.6. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-04-28,"Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China",https://doi.org/10.1007/s15010-020-01432-5,Infection,OR 2.64,0.86,8.05,0.09,Not Significant,,,,,,,,,Retrospective observational study,145,"Taizhou Public Health Medical Center, Zhejiang, China from Jan 1, 2020 to Mar 11, 2020",N,N,"['patients', 'ill', 'pubmed', 'article', 'severely']",2.64,,0,0,"Date: 2020-04-28. Study: Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Study Link: https://doi.org/10.1007/s15010-020-01432-5. Journal: Infection. Severe: OR 2.64. Severe Lower Bound: 0.86. Severe Upper Bound: 8.05. Severe p-value: 0.09. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 145. Study Population: Taizhou Public Health Medical Center, Zhejiang, China from Jan 1, 2020 to Mar 11, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: 2.64. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'ill', 'pubmed', 'article', 'severely']. "
2020-04-28,"Clinical determinants for fatality of 44,672 patients with COVID-19",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187660/,Critical Care,,,,,,OR 3.54,2.79,4.48,<0.01,Significant,Not Adjusted,"Extracted RR, Calculated OR",,Case series,44672,"Chinese center for disease control and prevention (44,672 laboratory confirmed cases updated through February 11, 2020, [2])",N,N,[],,3.54,0,0,"Date: 2020-04-28. Study: Clinical determinants for fatality of 44,672 patients with COVID-19. Study Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187660/. Journal: Critical Care. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 3.54. Fatality lower bound : 2.79. Fatality upper bound: 4.48. Fatality p-value: <0.01. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted RR, Calculated OR. Multivariate Adjustment: nan. Study Type: Case series. Sample Size: 44672. Study Population: Chinese center for disease control and prevention (44,672 laboratory confirmed cases updated through February 11, 2020, [2]). Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 3.54. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-27,Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196305/,Theranostics,OR 3.27,1.39,7.71,0.01,Significant,,,,,,,,,Retrospective observational study,421,Jiangsu province between 10 January and 18 February 2020.,Y,N,[],3.27,,0,0,Date: 2020-04-27. Study: Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients. Study Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196305/. Journal: Theranostics. Severe: OR 3.27. Severe Lower Bound: 1.39. Severe Upper Bound: 7.71. Severe p-value: 0.01. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 421. Study Population: Jiangsu province between 10 January and 18 February 2020.. Critical Only: Y. Discharged vs Death: N.Severe_number: 3.27. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. 
2020-04-27,Clinical characteristics and outcomes of patients with severe covid-19 with diabetes,https://www.ncbi.nlm.nih.gov/pubmed/32345579/,BMJ Open Diabetes Res Care,,,,,,OR 2.16,10.57,0.0,,Significant,Not Adjusted,Calculated,,Retrospective observational study,193,"Tongji Hospital (Wuhan, China) from January 10, 2020 to February 24, 2020;",N,N,"['patients', 'diabetes', 'severe', 'survival', 'admission']",,2.16,0,1,"Date: 2020-04-27. Study: Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. Study Link: https://www.ncbi.nlm.nih.gov/pubmed/32345579/. Journal: BMJ Open Diabetes Res Care. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 2.16. Fatality lower bound : 10.57. Fatality upper bound: 0.0. Fatality p-value: nan. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 193. Study Population: Tongji Hospital (Wuhan, China) from January 10, 2020 to February 24, 2020;. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 2.16. Severe_outside_bounds: 0. Fatality_outside_bounds: 1. Key word: ['patients', 'diabetes', 'severe', 'survival', 'admission']. "
2020-04-27,Estimating Survival of Hospitalized COVID-19 Patients from Admission Information,http://doi.org/10.1101/2020.04.22.20075416,medrxiv,,,,,,OR 1.59,1.38,1.83,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,5233,"Northwell Health acute care hospitals on or after March 1, 2020, and were discharged or died before April 12, 2020. Clinical outcomes (i.e., discharges, mortality, and length of stay) were monitored until April 12, 2020, the final date of follow-up",N,Y,"['author', 'health', 'find', 'northwell', 'research']",,1.59,0,0,"Date: 2020-04-27. Study: Estimating Survival of Hospitalized COVID-19 Patients from Admission Information. Study Link: http://doi.org/10.1101/2020.04.22.20075416. Journal: medrxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.59. Fatality lower bound : 1.38. Fatality upper bound: 1.83. Fatality p-value: <0.01. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 5233. Study Population: Northwell Health acute care hospitals on or after March 1, 2020, and were discharged or died before April 12, 2020. Clinical outcomes (i.e., discharges, mortality, and length of stay) were monitored until April 12, 2020, the final date of follow-up. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 1.59. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'health', 'find', 'northwell', 'research']. "
2020-04-26,ICU and ventilator mortality among critically ill adults with COVID-19,https://doi.org/10.1101/2020.04.23.20076737,MedRxiv,,,,,,OR 1.15,0.6,2.19,0.67,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,217,"ICU of Emory Healthcare acute-care hospitals in Atlanta, Georgia from March 6, 2020 through April 17, 2027",N,N,"['author', 'medicine', 'emory', 'find', 'care']",,1.15,0,0,"Date: 2020-04-26. Study: ICU and ventilator mortality among critically ill adults with COVID-19. Study Link: https://doi.org/10.1101/2020.04.23.20076737. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.15. Fatality lower bound : 0.6. Fatality upper bound: 2.19. Fatality p-value: 0.67. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 217. Study Population: ICU of Emory Healthcare acute-care hospitals in Atlanta, Georgia from March 6, 2020 through April 17, 2027. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.15. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'medicine', 'emory', 'find', 'care']. "
2020-04-25,The role of comorbidities and clinical predictors of severe disease in COVID-19: a systematic review and meta-analysis Emails,http://doi.org/10.1101/2020.04.21.20074633,,OR 3.54,1.79,7.01,,Significant,,,,,,,,,Systematic review and meta-analysis,9 studies,"PubMed, Scopus, EMBASE, Web of Science, and Google Scholar searched through March 12 2021",Y,N,"['author', 'shiraz', 'find', 'health', 'medicine']",3.54,,0,0,
2020-04-25,Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up,doi.org/10.1101/2020.04.21.20074641,medrxiv,,,,,,OR 1.39,0.73,2.64,0.29,Not Significant,Adjusted,Extracted,"Age, ICU admission, PCR test results, admission week, number of comorbidities, cardiovascular disease, chronic lung disease, gender, chronic kidney disease, immunodeficiency, hypertension",Retrospective observational study,1197,"Qazvin province hospitals Feb 20-March 11, 2020",N,N,[],,1.39,0,0,"Date: 2020-04-25. Study: Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up. Study Link: doi.org/10.1101/2020.04.21.20074641. Journal: medrxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.39. Fatality lower bound : 0.73. Fatality upper bound: 2.64. Fatality p-value: 0.29. Fatality Significant: Not Significant. Fatality Adjusted: Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: Age, ICU admission, PCR test results, admission week, number of comorbidities, cardiovascular disease, chronic lung disease, gender, chronic kidney disease, immunodeficiency, hypertension. Study Type: Retrospective observational study. Sample Size: 1197. Study Population: Qazvin province hospitals Feb 20-March 11, 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.39. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-24,"COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes",https://doi.org/10.1101/2020.04.20.20072421,medrxiv,OR 2.17,0.69,6.83,0.19,Not Significant,,,,,,,,,Retrospective observational study,100,"YAS hospital affiliated to Tehran University of Medical Sciences from Feb 22 to March 5, 2020",Y,N,"['author', 'find', 'iran', 'tehran', 'search']",2.17,,0,0,"Date: 2020-04-24. Study: COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes. Study Link: https://doi.org/10.1101/2020.04.20.20072421. Journal: medrxiv. Severe: OR 2.17. Severe Lower Bound: 0.69. Severe Upper Bound: 6.83. Severe p-value: 0.19. Severe Significant: Not Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 100. Study Population: YAS hospital affiliated to Tehran University of Medical Sciences from Feb 22 to March 5, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 2.17. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['author', 'find', 'iran', 'tehran', 'search']. "
2020-04-23,Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis,https://doi.org/10.1016/j.jinf.2020.04.021,Journal of Infection,OR: 3.68,2.68,5.03,,Significant,,,,,,,,,Systematic review and meta-analysis,3033 patients from 13 studies,China,Y,N,['redirecting'],3.68,,0,0,Date: 2020-04-23. Study: Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Study Link: https://doi.org/10.1016/j.jinf.2020.04.021. Journal: Journal of Infection. Severe: OR: 3.68. Severe Lower Bound: 2.68. Severe Upper Bound: 5.03. Severe p-value: nan. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 3033 patients from 13 studies. Study Population: China. Critical Only: Y. Discharged vs Death: N.Severe_number: 3.68. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. 
2020-04-23,Clinical Characteristics of Hospitalized Covid-19 Patients in New York City,http://medrxiv.org/cgi/content/short/2020.04.19.20062117v1?rss=1,MedRxiv,,,,,,OR 2.09,1.56,2.81,<0.05,Significant,Not Adjusted,Calculated,,Retrospective observational study,2199,"Mount Sinai Hospital located in East Harlem, Manhattan; Mount Sinai Morningside located in Morningside Heights, Manhattan; Mount Sinai West located in Midtown and the West Side, Manhattan; Mount Sinai Brooklyn located in Midwood, Brooklyn; and Mount Sinai Queens located in Astoria, Queens from Feb 27, 2020 to Apr 2, 2020",N,Y,"['patients', 'median', 'iqr', 'preprint', 'medrxiv']",,2.09,0,0,"Date: 2020-04-23. Study: Clinical Characteristics of Hospitalized Covid-19 Patients in New York City. Study Link: http://medrxiv.org/cgi/content/short/2020.04.19.20062117v1?rss=1. Journal: MedRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 2.09. Fatality lower bound : 1.56. Fatality upper bound: 2.81. Fatality p-value: <0.05. Fatality Significant: Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 2199. Study Population: Mount Sinai Hospital located in East Harlem, Manhattan; Mount Sinai Morningside located in Morningside Heights, Manhattan; Mount Sinai West located in Midtown and the West Side, Manhattan; Mount Sinai Brooklyn located in Midwood, Brooklyn; and Mount Sinai Queens located in Astoria, Queens from Feb 27, 2020 to Apr 2, 2020. Critical Only: N. Discharged vs Death: Y.Severe_number: nan. Fatality_number: 2.09. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['patients', 'median', 'iqr', 'preprint', 'medrxiv']. "
2020-04-23,"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy",doi.org/10.1016/j.thromres.2020.04.024,Thrombosis Research,OR 0.71,0.35,1.44,0.35,,,,,,,,,,Retrospective observational study,388,"Humanitas Clinical and Research Hospital,  since February 2021",Y,N,[],0.71,,0,0,"Date: 2020-04-23. Study: Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Study Link: doi.org/10.1016/j.thromres.2020.04.024. Journal: Thrombosis Research. Severe: OR 0.71. Severe Lower Bound: 0.35. Severe Upper Bound: 1.44. Severe p-value: 0.35. Severe Significant: nan. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 388. Study Population: Humanitas Clinical and Research Hospital,  since February 2021. Critical Only: Y. Discharged vs Death: N.Severe_number: 0.71. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
2020-04-21,Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology],https://doi.org/10.1016/j.jcv.2020.104378,Journal of Clinical Virology,,,,,,OR 1.24,0.66,2.34,0.51,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,2968,"Baqiyatallah hospital from 19 February 2020, to 15 April 2020",N,N,['redirecting'],,1.24,0,0,"Date: 2020-04-21. Study: Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology]. Study Link: https://doi.org/10.1016/j.jcv.2020.104378. Journal: Journal of Clinical Virology. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : OR 1.24. Fatality lower bound : 0.66. Fatality upper bound: 2.34. Fatality p-value: 0.51. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Calculated. Multivariate Adjustment: nan. Study Type: Retrospective observational study. Sample Size: 2968. Study Population: Baqiyatallah hospital from 19 February 2020, to 15 April 2020. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 1.24. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['redirecting']. "
2020-04-20,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",http://doi.org/10.1101/2020.04.15.20067157,medRxiv,,,,,,HR 0.89,0.57,1.39,,Not Significant,Not Adjusted,Extracted,,Prospective observational study,257,"Columbia University Irving Medical Center (2 affiliated hospitals in Manhattan) from March 2nd to April 1st, 2020.",N,N,"['new', 'author', 'york', 'ny', 'medicine']",,0.89,0,0,"Date: 2020-04-20. Study: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Study Link: http://doi.org/10.1101/2020.04.15.20067157. Journal: medRxiv. Severe: nan. Severe Lower Bound: nan. Severe Upper Bound: nan. Severe p-value: nan. Severe Significant: nan. Fatalyty : HR 0.89. Fatality lower bound : 0.57. Fatality upper bound: 1.39. Fatality p-value: nan. Fatality Significant: Not Significant. Fatality Adjusted: Not Adjusted. Fatality Calculated: Extracted. Multivariate Adjustment: nan. Study Type: Prospective observational study. Sample Size: 257. Study Population: Columbia University Irving Medical Center (2 affiliated hospitals in Manhattan) from March 2nd to April 1st, 2020.. Critical Only: N. Discharged vs Death: N.Severe_number: nan. Fatality_number: 0.89. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: ['new', 'author', 'york', 'ny', 'medicine']. "
2020-04-20,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",http://doi.org/10.1101/2020.04.15.20067157,,,,,,,AHR 1.28,0.77,2.13,,Not Significant,Adjusted,Extracted,"Age, gender, symptom duration prior to presentation, hypertension, cardiovascular disease, COPD and/or interstitial lung disease, chronic kidney disease, diabetes, BMI >= 35, IL-6, D-dimer",Prospective observational study,257,"Columbia University Irving Medical Center (2 affiliated hospitals in Manhattan) from March 2nd to April 1st, 2020.",N,N,"['new', 'author', 'york', 'ny', 'medicine']",,1.28,0,0,
2020-04-19,Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187729/,Research,OR 2.61,2.05,3.33,,Significant,,,,,,,,,Systematic review and meta-analysis,"31 studies, 6104 patients","PubMed, Embase, Web of Science, medRxiv, and bioRxiv databases for articles published through April 6, 2020",Y,N,[],2.61,,0,0,"Date: 2020-04-19. Study: Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Study Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187729/. Journal: Research. Severe: OR 2.61. Severe Lower Bound: 2.05. Severe Upper Bound: 3.33. Severe p-value: nan. Severe Significant: Significant. Fatalyty : nan. Fatality lower bound : nan. Fatality upper bound: nan. Fatality p-value: nan. Fatality Significant: nan. Fatality Adjusted: nan. Fatality Calculated: nan. Multivariate Adjustment: nan. Study Type: Systematic review and meta-analysis. Sample Size: 31 studies, 6104 patients. Study Population: PubMed, Embase, Web of Science, medRxiv, and bioRxiv databases for articles published through April 6, 2020. Critical Only: Y. Discharged vs Death: N.Severe_number: 2.61. Fatality_number: nan. Severe_outside_bounds: 0. Fatality_outside_bounds: 0. Key word: []. "
